Study of a new protein replacement therapy in healthy adults
This early study tests a new type of protein replacement therapy for healthy volunteers. The purpose is to see if it is safe and how the body handles it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 90 years old.
- You are generally healthy with no major active medical conditions.
- If you are of childbearing potential or have a partner who is, you must use effective birth control during the trial and for 90 days after.
- You should not have certain medical conditions such as autoimmune diseases, recent cancer, or kidney failure requiring dialysis.
- You must be willing and able to follow the study procedures and give written consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called QLS2312, given as an injection, to see if it is safe and how the body handles it. It is an early study in healthy volunteers that helps decide if the drug can be studied in people with certain conditions.
This trial tests a new drug called AK0610 in healthy volunteers aged 18 to 50. It helps researchers understand how the drug works in the body and whether it is safe before moving to larger studies.
This study is testing a new medication called AKB-9090 for the first time in people. It will help find out how the drug works in the body and how safe it is. The study is looking for healthy volunteers.
This early-stage trial tests a new medicine called AK152 in two groups: healthy volunteers and people with Alzheimer's disease or mild memory problems. For Alzheimer's patients, the study looks at whether the drug safely targets amyloid plaques in the brain.
This trial tests a new medicine called HL-003 in healthy people to see if it is safe and how the body processes it. You may join if you are generally healthy, between 18 and 50 years old, and meet specific health and lifestyle requirements.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
Hear when a new Aging trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.